Intelligent Extracorporeal Blood Treatment Systems

Publication ID: 24-11857715_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Extracorporeal Blood Treatment Systems,” Published Technical Disclosure No. 24-11857715_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857715_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,715.

Summary of the Inventive Concept

The present invention integrates AI, IoT, blockchain, and nanomaterials with extracorporeal blood treatment devices to create a more efficient, patient-centric, and data-driven system.

Background and Problem Solved

The original patent disclosed an extracorporeal blood treatment apparatus with a blood-warming device. However, it lacked advanced data management, real-time monitoring, and adaptive control capabilities. The new inventive concept addresses these limitations by incorporating synergistic technologies to enhance patient safety, treatment efficacy, and data integrity.

Detailed Description of the Inventive Concept

The inventive concept comprises an extracorporeal blood treatment device, a blood warmer, and an extracorporeal blood circuit. Additionally, it integrates a blockchain-based data management system for secure and transparent treatment data tracking, an IoT-enabled sensor for real-time monitoring of priming parameters, and an AI-powered control system for optimizing treatment parameters based on patient data. Furthermore, a nanomaterial-based coating can be applied to reduce blood clotting and improve biocompatibility. The system enables personalized treatment, predictive maintenance, and remote monitoring, improving overall treatment outcomes.

Novelty and Inventive Step

The new claims introduce the innovative combination of AI, IoT, blockchain, and nanomaterials with extracorporeal blood treatment devices, providing a synergistic system that enhances patient safety, treatment efficacy, and data integrity. This integration is non-obvious and novel compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT protocols, or blockchain platforms. Variations may involve integrating additional sensors, actuators, or data analytics tools to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of extracorporeal blood treatment, patient monitoring, and personalized medicine. The target market includes hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61M1/369
A A61 A61M1/3623
A A61 A61M1/3626
A A61 A61M1/3627
A A61 A61M1/3643
A A61 A61M39/28
A A61 A61M2205/3344
A A61 A61M2205/36

Original Patent Information

Patent NumberUS 11,857,715
TitleExtracorporeal blood treatment apparatus
Assignee(s)Gambro Lundia AB